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SUPPLEMENTARY METHODS 
Potential confounders in G1 
The age of participants at baseline was derived by the UK Biobank based on their date of birth and 
date of attending the initial assessment. We used Townsend deprivation index and household 
income as measures of socio-economic position at baseline. Townsend deprivation index is a score 
measuring material deprivation in the area where participants were living, calculated by UK Biobank 
using participants’ postcode. Participants (except those who living in sheltered accommodation or a 
care home) were asked to report their average total household income before tax, with five 
categories ranging from less than £18 000 to greater than £100 000. Sex of participants was acquired 
from the registry and updated by the participants. 
Supplementary Table 5 summarised the UK Biobank fields we used to derive our smoking 
phenotypes, outcomes, and confounders. 
 
Simulation 
We performed two simulations to compare statistical power of proxy G×E MR to that of G×E MR 
(where maternal [G0] genotype is available).  
Simulation A is for offspring (G1) early life outcomes (e.g. birthweight) that should not be affected by 
G1 smoking, and thus we will not stratify on G1 smoking status. We generated simulated data 
according to the directed acyclic graphs shown in Supplementary Figure 6A, using the following 
steps:  
(1) We generated G0 rs16969968 according to the allelic dosage distribution in UK Biobank.  
(2) We generated G1 rs16969968 according to both the allelic dosage distribution in UK Biobank 
and G0 rs16969968. For example, mothers with dosage 1 could have offspring with dosage 0, 1 or 
2, with probabilities (1 - effect allele frequency [EAF])/2, 1/2 and EAF/2, respectively. The 
proportions of G0 and G1 in each dosage were shown in Supplementary Figure 6B.  
(3) We generated G0 smoking status in pregnancy according to its proportion of smokers and 
non-smokers in UK Biobank.  
(4) Among smokers, we generated G0 smoking heaviness as a linear effect of G0 rs16969968 (1 
cigarette/day/allele(1)) and log-normal distributed random error (as observed in UK Biobank). 
(5) We generated a standardised continuous outcome in the offspring (G1). Among G0 non-
smokers this was generated randomly from a normal distribution. Among G0 smokers, we 
generated the outcome as a linear function of G0 smoking heaviness and normally distributed 
random error (as was used for non-smokers). 
We repeated our simulation A with different effect sizes of G0 smoking heaviness (i.e. 0.01, 0.025, 
0.05, 0.075 and 0.1 SD/cigarette) for step (5) and different total sample sizes (i.e. 100 000, 500 000, 
1 000 000 and 5 000 000). Given an effect size and a sample size, we simulated 1000 times. In each 
time, we stratified on G0 smoking status, estimated G0 rs16969968 – G1 outcome associations for 
G×E MR and G1 rs16969968 – G1 outcome associations for proxy G×E MR in each stratum, and then 
identified the strength of interaction between G0 strata using Cochran’s Q test for heterogeneity.  
Simulation B is for G1 later life outcomes (e.g. adulthood body mass index [BMI]) that would be 
affected by G1 smoking, and thus we will further stratify on G1 smoking status. We generated 
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simulated data in the same way as steps (1-4). We also generated G1 smoking status and G1 
smoking heaviness following the same rules in steps (3-4). Finally, we generated a standardised 
continuous outcome in G1. Among G1 non-smokers, this was generated in the same way as step (5). 
Among G1 smokers, we further include a linear effect of G1 smoking heaviness (0.1 SD/cigarette). 
We repeated our simulation B in the same way as A. In each time, we stratified on both G0 and G1 
smoking status, estimated those genetic associations in A, and then within each G1 stratum 
identified the strength of interaction between G0 strata (e.g. G0 smokers & G1 smokers versus G0 
non-smokers & G1 smokers). 
Given an effect size and a sample size, the statistical power would be the times (when the 
interaction P-value is smaller than 0.05) out of 1000. We plotted the power in Supplementary Figure 
5. Simulation code is provided in the GitHub repository [https://github.com/MRCIEU/MR-maternal-
smoking/tree/master/power_simulation].  
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SUPPLEMENTARY FIGURES 
Supplementary Figure 1. Participant flow diagram 
 
Note: The 463,013 participants are of European descent, have genetic sex same as reported sex, 
either XX or XY in sex chromosome, and no outliers in heterozygosity and missing rates.(2) 
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Supplementary Figure 2. Illustration of edge cases when deriving participants smoking in 
pregnancy 
A) Participants started smoking in the same year as the first live birth (N=538) 
 
 
 
 
         
 
 
B) Participants stopped smoking in the same year as the first live birth (N=1129) 
 
 
 
 
        
 
 
C) Participants stopped smoking in the year before the first live birth (N=1017) 
 
 
 
 
        
 
 
This figure illustrates our derivation of female participants smoking status in their pregnancy 
resulting in their first live birth. For example, a participant reporting her first live birth occurring at 
25 years old could have been pregnant at 25 years old only, or both 24 and 25 years old. If she was a 
current smoker and started smoking at 25 years old, it was unknown if this was after or during her 
pregnancy (Supplementary Figure 2A). If she was a current smoker and started smoking at 24 years 
old, she smoked at least in her late pregnancy. Similarly, if she stopped smoking at 24 or 25 years old 
(Supplementary Figure 2B&C), it was unknown if this was before or during their pregnancy. If she 
stopped smoking at 23 years old, she did not smoke during her pregnancy. 
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Supplementary Figure 3. Directed acyclic graphs (DAGs) illustrating potential collider bias 
(A) G×E MR stratifying on maternal (G0) smoking status in pregnancy 
 
(B) G×E MR stratifying on both maternal (G0) smoking status during pregnancy and offspring (G1) 
smoking status 
 
(C) G×E MR testing the effect of grandmother (G0) smoking on grandchild (G2) birthweight, by 
stratifying on both G0 smoking status in pregnancy and G1 smoking status in pregnancy 
 
These DAGs show example alternative pathways that may bias associations between the variant and 
the outcome, due to conditioning on a collider. 
Generation (G)0: UK Biobank participants’ mother; G1: UK Biobank participants themselves; G2: First 
child of UK Biobank women participants.  
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Boxes around a phenotype denote this phenotype is being conditioned upon. Blue solid arrow 
denotes known association, blue dashed arrow denotes the hypothesis we are testing, and red 
dashed-dotted arrows denote that conditioning on the collider induced an association between 
parents of the collider – i.e. an association between genotype and the confounders.  
(A) The smoking heaviness variant (rs16969968) has been shown to influence smoking status in 
pregnancy.(3) In this DAG, G1 birthweight is related to G0 smoking status in pregnancy because 
they have a common cause (e.g. G0 socioeconomic status [SES]). Therefore, G0 smoking status in 
pregnancy would be a collider such that conditioning on it induces an alternative pathway 
between rs16969968 and G1 birthweight that is not via smoking heaviness (shown as ). 
This may bias the association of rs16969968 with G1 birthweight. For example, G0 individuals 
with more smoking-increasing alleles would be more likely to smoke in pregnancy. G0 individuals 
with lower SES would be more likely to smoke in pregnancy and concurrently have a lower G1 
birthweight. The observed association of G0 rs16969968 with G1 birthweight would include not 
only the true adverse effect via G0 smoking heaviness but also an adverse effect via conditioning 
on G0 smoking status in pregnancy, and thus bias the true estimate away from the null. 
(B) Besides the potential collider bias described in (A), our proxy (i.e. G1 rs16969968) is weakly 
associated with G1 smoking status. In this DAG, G1 later life outcomes are also related to G1 
smoking status via a common cause (e.g. G1 SES). Therefore, G1 smoking status would be a 
collider such that conditioning on it induces an alternative pathway between rs16969968 with 
G1 later life outcomes that is not via smoking heaviness (shown as ). This may bias the 
association of rs16969968 with G1 later life outcomes.  
(C) Besides the potential collider bias described in (A), our proxy (i.e. G1 rs16969968) is associated 
with female G1 smoking status in pregnancy. In this DAG, G2 birthweight is related to female G1 
smoking status in pregnancy because they have common causes (e.g. G1 SES). Therefore, female 
G1 smoking status in pregnancy would be a collider such that conditioning on it induces an 
alternative pathway between rs16969968 with G2 birthweight that is not via smoking heaviness 
(shown as ). This may bias the association of rs16969968 with G2 birthweight.  
Other sources of bias regarding conditioning on a downstream effect (e.g. missingness) of exposures 
or outcomes have been discussed by Hughes et al.(4) 
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Supplementary Figure 4. The associations of G1 rs16969968 with G1 height and age at menarche in 
sensitivity analyses 
 
Generation (G)0: UK Biobank participants’ mother; G1: UK Biobank participants themselves. 
Estimates are the mean difference of G1 outcome per each smoking-heaviness increasing allele of 
rs16969968. G1 were grouped according to whether they were ever smokers before achieving their 
adulthood height or their age at menarche. G1 who started smoking at the same age of achieving 
their adulthood height or at menarche were removed from analyses due to uncertainty. 
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Supplementary Figure 5. Comparison of statistical power between gene-by-environment (G×E) Mendelian randomization (MR) and proxy G×E MR  
 
*For example, if the outcome is G1 age at menarche and its SD is 1.6 years in UK Biobank, 0.01 SD/cigarette will be equivalent to 5.84 days/cigarette.  
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Supplementary Figure 6. Data generation mechanism for the simulation 
(A)  
 
(B) 
 
*The effect allele frequency is 33% in UK Biobank participants, and we assume this frequency 
remains the same in their mothers and fathers.  
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SUPPLEMENTARY TABLES 
Supplementary Table 1. Characteristics of the UK Biobank participants (G1) by their sex 
Variable Total N 
Sex1 
Men Women 
Smoking 
Maternal (G0) smoking in pregnancy                     Yes 88 447 41 793 (31.5) 46 656 (29.7) 
 No 201 237 90 889 (68.5) 110 348 (70.3) 
Smoking status of participants (G1)                Current    27 420 14 924 (11.3) 12 496 (8.0) 
 Former 99 932 51 209 (38.7) 48 723 (31.1) 
 Never 161 398 66 108 (50.0) 95 290 (60.9) 
Participants (G1) smoking in pregnancy2               Yes 19 061 
Not applicable 
19 061 (19.1) 
 No 80 552 80 552 (80.9) 
Outcome in participants (G1) 
Birthweight (kg) 171 784 3.45 ± 0.68 3.24 ± 0.63 
Standing height (cm) 289 050 176.04 ± 6.75 162.77 ± 6.22 
Body mass index (kg/m2) 288 775 27.79 ± 4.21 26.98 ± 5.12 
Forced vital capacity (L) 218 378 4.48 ± 0.87 3.21 ± 0.63  
Forced expiratory volume in 1-second (L) 218 378 3.37 ± 0.73 2.44 ± 0.52 
Asthma Case  30 751 13 008 (9.8) 17 743 (14.6) 
 Control3 258 639 119 531 (90.2) 139 108 (88.7) 
Age at menarche (year) 152 991 Not applicable 12.95 ± 1.60 
Systolic blood pressure (mmHg) 289 430 141.15 ± 17.44 135.33 ± 19.13  
Diastolic blood pressure (mmHg) 289 431 84.14 ± 10.00 80.64 ± 9.95  
Year of Education (year) 287 198 15.44 ± 5.06 14.63 ± 5.05 
Fluid intelligence score  148 462 6.17 ± 2.18 5.95 ± 2.03 
Depression/anxiety Case  102 637 36 333 (27.4) 66 304 (42.3) 
 Control 186 743 96 197 (72.6) 90 546 (57.7) 
Happiness Extremely happy 5417 2727 (6.2) 2690 (5.2) 
 Very happy 37 872 17 670 (40.1) 20 202 (39.2) 
 Moderately happy 48 223 21 618 (49.0) 26 605 (51.6) 
 Moderately unhappy 3358 1677 (3.8) 1681 (3.3) 
 Very unhappy 566 283 (0.6) 283 (0.5) 
 Extremely unhappy 188 108 (0.2) 80 (0.2) 
Outcome in the first child of female participants (G2) 
Birthweight (kg) 126 122 Not applicable 3.19 ± 0.55 
Potential confounder in participants (G1) 
Age (year) 289 684 56.97 ± 8.12 56.48 ± 7.95 
Age at first live birth (years) 107 277 Not applicable 25.48 ± 4.55  
Deprivation index 289 334  -1.59 ± 2.96 -1.64 ± 2.86 
Household income less than £18,000 52 806 22 438 (18.7) 30 369 (23.1) 
 £18,000 to £30,999 63 807 29 168 (24.3) 34 644 (26.4) 
 £31,000 to £51,999 66 999 32 887 (27.4) 34 117 (26.0) 
 £52,000 to £100,000 53 588 27 878 (23.2) 25 712 (19.6) 
 greater than £100,000 14 235 7659 (6.4) 6576 (5.0) 
1 Mean ± standard deviation for continuous variables and N (column %) for categorical variables. 
2 Participants smoking in pregnancy was derived from G1 age at first live birth and the ages they 
reported starting and stopping smoking. As these ages were recorded as a whole number of years, it 
was not always possible to determine whether a woman was a smoker in pregnancy (see the 
Methods section in the main paper and Supplementary Figure 2 for details). 
3 Controls were participants who did not indicate having asthma diagnosed by a doctor.  
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Supplementary Table 2. Associations of G1 rs16969968 with potential confounders by strata of smoking status in participants (G1) and their mothers 
(G0), adjusted for the first ten principal components 
Confounder By G1 smoking status Overall 
By G0 smoking status in pregnancy 
Yes No 
Age (years)1 All participants -0.018 (-0.062, 0.026) -0.080 (-0.156, -0.004) 0.013 (-0.040, 0.067) 
 Current smokers -0.073 (-0.218, 0.072) -0.092 (-0.325, 0.141) -0.061 (-0.245, 0.124) 
 Former smokers -0.076 (-0.149, -0.006) -0.044 (-0.170, 0.083) -0.087 (-0.174, -0.001) 
 Ever smokers -0.089 (-0.154, -0.024) -0.062 (-0.175, 0.051) -0.097 (-0.176, -0.017) 
 Never smokers 0.054 (-0.005, 0.113) -0.074 (-0.177, 0.028) 0.113 (0.041, 0.185) 
     
 Female participants 0.013 (-0.046, 0.072) -0.059 (-0.163, 0.045) 0.049 (-0.022, 0.121) 
 Female smokers in pregnancy -0.159 (-0.315, -0.003) 0.037 (-0.215, 0.290) -0.291 (-0.484, -0.095) 
 Female non-smokers in pregnancy 0.055 (-0.026, 0.136) -0.077 (-0.220, 0.067) 0.121 (0.023, 0.220) 
     
Age at first live birth (years)1 Female participants 0.019 (-0.022, 0.060) 0.050 (-0.024, 0.125) 0.015 (-0.034, 0.063) 
 Female smokers in pregnancy 0.015 (-0.072, 0.101) 0.010 (-0.128, 0.148) 0.017 (-0.093, 0.127) 
 Female non-smokers in pregnancy 0.024 (-0.026, 0.074) 0.068 (-0.026, 0.163) 0.017 (-0.041, 0.076) 
     
Deprivation index1 All participants 0.010 (-0.006, 0.026) 0.002 (-0.029, 0.032) 0.011 (-0.007, 0.030) 
 Current smokers 0.018 (-0.042, 0.079) 0.019 (-0.084, 0.123) 0.018 (-0.056, 0.093) 
 Former smokers 0.008 (-0.019, 0.035) -0.014 (-0.065, 0.038) 0.015 (-0.017, 0.047) 
 Ever smokers 0.016 (-0.010, 0.041) -0.002 (-0.050, 0.045) 0.022 (-0.008, 0.051) 
 Never smokers 0.012 (-0.008, 0.032) 0.014 (-0.024, 0.052) 0.009 (-0.014, 0.032) 
     
 Female participants -0.002 (-0.023, 0.019) -0.018 (-0.059, 0.023) 0.002 (-0.022, 0.027) 
 Female smokers in pregnancy -0.026 (-0.092, 0.040) -0.098 (-0.208, 0.011) 0.021 (-0.062, 0.103) 
 Female non-smokers in pregnancy -0.002 (-0.029, 0.026) -0.022 (-0.076, 0.031) 0.002 (-0.029, 0.034) 
     
Years of education1 All participants 0.036 (0.008, 0.064) 0.045 (-0.006, 0.097) 0.036 (0.003, 0.069) 
 Current smokers 0.030 (-0.064, 0.124) 0.092 (-0.065, 0.249) -0.006 (-0.123, 0.111) 
 Former smokers 0.043 (-0.005, 0.091) 0.022 (-0.068, 0.112) 0.055 (-0.003, 0.112) 
 Ever smokers 0.038 (-0.006, 0.081) 0.038 (-0.040, 0.117) 0.040 (-0.012, 0.091) 
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1 Results were from linear regression. Estimates are mean difference of confounder per each smoking-heaviness increasing allele of rs16969968. 
2 Results were from ordinal logistic regression for household income (less than £18 000 = 1, £18 000 to £30 999 = 2, £31 000 to £51 999 = 3, £52 000 to £100 
000 = 4, greater than £100 000 = 5). Estimates are the change in odds of being in a higher level of household income per each smoking-heaviness increasing 
allele of rs16969968. 
3 Results from logistic regression for sex. Estimates are the change in odds of being male rather than female per each smoking-heaviness increasing allele of 
rs16969968. 
  
 Never smokers 0.026 (-0.010, 0.062) 0.036 (-0.032, 0.103) 0.026 (-0.017, 0.069) 
     
 Female participants 0.050 (0.012, 0.088) 0.064 (-0.006, 0.133) 0.049 (0.005, 0.094) 
 Female smokers in pregnancy 0.035 (-0.074, 0.144) 0.155 (-0.022, 0.332) -0.038 (-0.176, 0.100) 
 Female non-smokers in pregnancy 0.046 (-0.006, 0.098) 0.095 (-0.002, 0.191) 0.033 (-0.029, 0.095) 
     
Household income  All participants 0.996 (0.986, 1.007) 0.992 (0.974, 1.011) 0.998 (0.986, 1.011) 
(compare to less than £18,000)2 Current smokers 0.979 (0.947, 1.013) 0.980 (0.926, 1.037) 0.978 (0.937, 1.021) 
 Former smokers 0.993 (0.975, 1.010) 0.995 (0.963, 1.028) 0.992 (0.971, 1.013) 
 Ever smokers 0.988 (0.972, 1.004) 0.990 (0.962, 1.018) 0.987 (0.969, 1.006) 
 Never smokers 0.999 (0.985, 1.013) 0.988 (0.963, 1.013) 1.003 (0.987, 1.020) 
     
 Female participants 0.994 (0.980, 1.009) 0.991 (0.965, 1.018) 0.996 (0.979, 1.014) 
 Female smokers in pregnancy 1.000 (0.959, 1.043) 1.012 (0.946, 1.082) 0.991 (0.940, 1.046) 
 Female non-smokers in pregnancy 1.006 (0.986, 1.027) 1.004 (0.967, 1.042) 1.008 (0.984, 1.033) 
     
Sex (compare to female)3 All participants 0.995 (0.984, 1.006) 0.987 (0.967, 1.007) 0.998 (0.985, 1.011) 
 Current smokers 0.994 (0.959, 1.030) 0.992 (0.935, 1.052) 0.995 (0.951, 1.041) 
 Former smokers 1.004 (0.985, 1.023) 1.005 (0.972, 1.040) 1.003 (0.981, 1.026) 
 Ever smokers 1.002 (0.986, 1.019) 1.003 (0.973, 1.033) 1.002 (0.982, 1.023) 
 Never smokers 0.993 (0.978, 1.008) 0.977 (0.951, 1.004) 0.999 (0.981, 1.017) 
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Supplementary Table 3. Differences in the associations of rs16969968 with 12 outcomes in 
participants (G1) across maternal (G0) smoking status in pregnancy 
1 We combined current and former smokers into ever smokers for some outcomes given smoking 
cessation may not influence them rapidly. 
2 Interaction P-value was obtained using Cochran’s Q statistic for the heterogeneity in the 
association of rs16969968 with each outcome between participants whose mothers did versus did 
not smoke.  
G1 outcome (associations shown in Figure 2) By G1 smoking status1 Interaction P-value2 
Height All participants 0.2415 
 Never smokers 0.0291 
 Ever smokers 0.5491 
Body mass index All participants 0.8710 
 Never smokers 0.4258 
 Former smokers 0.2756 
 Current smokers 0.7849 
Forced expiratory volume in 1-second All participants 0.4603 
 Never smokers 0.6462 
 Former smokers 0.4970 
 Current smokers 0.7575 
Forced vital capacity All participants 0.6788 
 Never smokers 0.3199 
 Former smokers 0.9120 
 Current smokers 0.1879 
Asthma All participants 0.9756 
 Never smokers 0.7751 
 Ever smokers 0.8507 
Systolic blood pressure All participants 0.3985 
 Never smokers 0.2725 
 Former smokers 0.7075 
 Current smokers 0.5221 
Diastolic blood pressure All participants 0.5861 
 Never smokers 0.9896 
 Former smokers 0.1164 
 Current smokers 0.2265 
Age at menarche All participants 0.7269 
 Never smokers 0.8938 
 Ever smokers 0.8250 
Year of education All participants 0.9796 
 Never smokers 0.8282 
 Ever smokers 0.8791 
Fluid intelligence score All participants 0.9067 
 Never smokers 0.2581 
 Former smokers 0.1856 
 Current smokers 0.8321 
Depression/anxiety All participants 0.8368 
 Never smokers 0.8355 
 Former smokers 0.9112 
 Current smokers 0.6190 
Happiness All participants 0.0668 
 Never smokers 0.1529 
 Ever smokers 0.2689 
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Supplementary Table 4. Observational associations of participants mothers’ (G0) smoking in pregnancy with participants’ (G1) smoking status and all 
outcomes 
1 Model 1 adjusted for G1 age; Model 2 adjusted for G1 age, smoking status, education and Townsend deprivation index. 
2 Model 1 adjusted for G1 age; Model 2 adjusted for G1 age, smoking status in pregnancy, education and Townsend deprivation index. 
  
Dependent variables Model 1  Model 2 
Smoking in participants (G1) OR (95% CI) P-value    
Smoking status (ever vs never) 1.073 (1.056, 1.090) 3.7×10-18  Not applicable 
Smoking in pregnancy (smoker vs non-smoker) 1.494 (1.446, 1.544) 1.3×10-126  Not applicable 
Outcome in participants (G1) Mean difference (95% CI) P-value  Mean difference (95% CI) P-value 
Birthweight (kg)1 -0.104 (-0.111, -0.097) 6.6×10-198  -0.101 (-0.107, -0.094)  1.1×10-182 
Standing height (cm)1 -0.509 (-0.582, -0.437) 8.2×10-43  -0.273 (-0.345, -0.200) 1.6×10-13 
Body mass index (kg/m2)1 0.850 (0.813, 0.888) ~0  0.732 (0.695, 0.770) 1.9×10-319 
Forced vital capacity (L)1 -0.037 (-0.045, -0.028) 4.7×10-17  -0.010 (-0.018, -0.001) 2.3×10-2 
Forced expiratory volume in 1-second (L)1 -0.038 (-0.044, -0.031) 4.0×10-29  -0.015 (-0.022, -0.008) 7.4×10-6 
 OR (95% CI) P-value  OR (95% CI) P-value 
Asthma (case vs control)1 1.073 (1.047, 1.101) 4.2×10-8  1.075 (1.048, 1.103) 3.5×10-8 
 Mean difference (95% CI) P-value  Mean difference (95% CI) P-value 
Age at menarche (year)1 -0.056 (-0.074, -0.039) 3.5×10-10  -0.070 (-0.087, -0.052) 1.3×10-14 
Systolic blood pressure (mmHg)1 0.517 (0.377, 0.656) 3.7×10-13  0.436 (0.296, 0.577) 1.2×10-9 
Diastolic blood pressure (mmHg)1 0.413 (0.333, 0.493) 5.4×10-24  0.393 (0.312, 0.474) 1.9×10-21 
Year of Education1 -0.796 (-0.836, -0.757) ~0  Not applicable 
Fluid intelligence score1  -0.236 (-0.259, -0.212) 1.8×10-87  -0.132 (-0.154, -0.110) 2.0×10-31 
 OR (95% CI) P-value  OR (95% CI) P-value 
Depression/anxiety (case vs control)1 1.191 (1.172, 1.211) 4.9×10-97  1.160 (1.141, 1.179) 5.3×10-68 
Happiness (extremely happy to extremely unhappy)1 0.940 (0.915, 0.965) 4.8×10-6  0.958 (0.932, 0.984) 1.7×10-3 
Outcome in the first child of female participants (G2) Mean difference (95% CI) P-value  Mean difference (95% CI) P-value 
Birthweight (kg)2 -0.003 (-0.009, 0.004) 0.44  0.013 (0.005, 0.020) 6.2×10-4 
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Supplementary Table 6. UK Biobank data field of variables used in this study 
Variable UK Biobank data field 
Smoking phenotypes 
Maternal smoking around birth 1787 
Smoking status 20116 
Age started smoking in current smokers 3436 
Age started smoking in former smokers 2867 
Age stopped smoking 2897 
  
Outcomes  
Birth weight 20022 
Standing height 50 
Body mass index (BMI) 21001 
Forced expiratory volume in 1-second (FEV1), Best measure 20150 
Forced vital capacity (FVC), Best measure 20151 
Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy 
diagnosed by doctor 
6152 
Systolic blood pressure, automated reading 4080 
Systolic blood pressure, manual reading 93 
Diastolic blood pressure, automated reading 4079 
Diastolic blood pressure, manual reading 94 
Age when periods started (menarche) 2714 
Qualifications 6138 
Fluid intelligence score 20016, 20191 
Seen doctor (GP) for nerves, anxiety, tension or depression 2090 
Seen a psychiatrist for nerves, anxiety, tension or depression 2100 
Diagnoses - main ICD10 41202 
Diagnoses - secondary ICD10 41204 
Happiness 4526 
Birth weight of first child 2744 
  
Potential confounder 
Age at recruitment 21022 
Age at first live birth 2754 
Sex 31 
Townsend deprivation index at recruitment 189 
Average total household income before tax 738 
Further information on these phenotypes can be found by searching the UK Biobank data showcase: 
http://biobank.ctsu.ox.ac.uk/showcase/search.cgi. 
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